E72.21 Argininemia

Name of the Condition

• Argininemia (ICD-10 Code: E72.21)

Summary

Argininemia is a rare genetic disorder affecting the urea cycle, where the body cannot properly remove ammonia from the blood. This results in elevated levels of ammonia, which is toxic and can lead to severe health issues. The condition is caused by a deficiency in the enzyme arginase, which is essential for converting arginine into urea and ornithine in the urea cycle.

Causes

Argininemia is caused by mutations in the ARG1 gene, which encodes the enzyme arginase. It is inherited in an autosomal recessive pattern, meaning an individual must inherit two mutated copies of the gene (one from each parent) to develop the condition. These mutations disrupt the normal breakdown of arginine, leading to its accumulation and impaired ammonia detoxification.

Risk Factors

• Family history of argininemia or other urea cycle disorders.
• Consanguinity (parents who are close relatives) increasing the likelihood of inheriting recessive mutations.
• Ethnic or geographic prevalence of specific ARG1 gene variants in certain populations.

Symptoms

• Neurological symptoms such as lethargy, seizures, developmental delays, or intellectual disability.
• Gastrointestinal issues like vomiting, poor feeding, or failure to thrive.
• Ataxia (loss of coordination) and spasticity (muscle stiffness).
• Hyperammonemia (elevated ammonia levels) may present with acute encephalopathy.

Diagnosis

Diagnosis typically involves measuring plasma or urine amino acid levels, which show elevated arginine. Genetic testing confirms mutations in the ARG1 gene. Newborn screening may detect elevated arginine levels, prompting further evaluation. Enzyme activity assays in red blood cells or liver tissue can also support the diagnosis.

Treatment Options

Treatment focuses on reducing ammonia levels and managing symptoms. This includes a protein-restricted diet, essential amino acid supplements, and medications to enhance ammonia excretion (e.g., sodium phenylbutyrate). Regular monitoring of metabolic parameters and neurological function is critical. In severe cases, liver transplantation may be considered.

Prognosis and Follow-Up

With early diagnosis and strict management, outcomes can improve, but neurological damage may be irreversible. Long-term follow-up with metabolic specialists, regular monitoring of ammonia and amino acid levels, and developmental assessments are essential. Prognosis varies based on the timeliness of intervention and adherence to treatment.

Complications

• Persistent neurological impairment, including intellectual disability or motor deficits.
• Recurrent hyperammonemic episodes, which can be life-threatening.
• Growth failure due to dietary restrictions.
• Liver dysfunction in advanced cases.

Lifestyle & Prevention

• Adherence to a specialized diet low in protein and arginine, guided by a metabolic dietitian.
• Avoidance of triggers like illness or fasting, which can increase ammonia production.
• Regular medical check-ups to monitor metabolic status and adjust treatment as needed.
• Genetic counseling for families to understand inheritance risks.

When to Seek Professional Help

Seek immediate medical attention for symptoms of hyperammonemia, such as lethargy, seizures, or altered mental status. Consult a metabolic specialist for ongoing management of dietary and treatment plans. Regular follow-up is necessary to prevent complications.

Tips for Medical Coders

Document the specific enzyme deficiency (arginase) and genetic confirmation (ARG1 mutations) when available, as these details support the diagnosis. Note any associated complications, such as neurological impairment or hyperammonemia, to ensure comprehensive coding. Ensure documentation aligns with clinical findings to justify the use of E72.21.